Clinical Trial Update: Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

View source ↗

Summary

A completed survey sponsored by AstraZeneca assessing undertreatment of hypercholesterolemia across the Pan-Middle East.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Status: COMPLETED